Maxcyte MXCT Income Statement (2020-2026)

NASDAQ MXCT
$1.38 0.00 (-0.36%)
At close: Aug 20, 2026 · 10:49 AM UTC
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
100.43M101.20M101.51M101.66M101.90M102.40M102.90M103.13M103.55M103.96M104.41M104.82M105.30M105.71M106.31M106.59M106.64M106.79M107.12M106.13M
Revenue & cost
Revenue (Quarter)
10.14M7.51M11.59M9.61M10.64M7.76M4.96M9.04M4.16M26.55M5.58M4.96M8.16M6.05M10.39M8.51M6.83M-4.77M4.50M7.27M
Gross Profit (Quarter)
9.20M8.93M10.52M8.49M9.27M10.88M7.58M7.67M7.21M14.09M9.94M8.94M6.24M6.41M8.89M6.99M5.23M5.69M8.08M5.60M
Operating items
Research & Development (Quarter)
3.21M0.98M3.84M4.93M5.33M5.73M6.05M5.66M7.05M4.04M7.37M6.62M5.32M2.04M5.90M6.27M5.32M3.50M3.86M4.25M
Selling, General & Administrative (Quarter)
5.35M6.03M6.63M7.10M6.44M5.65M7.50M7.66M6.82M8.09M7.10M7.64M7.75M7.21M8.53M8.08M6.03M5.48M5.97M7.26M
Restructuring Costs (Quarter)
3.06M
Other Operating Expenses (Quarter)
3.08M6.88M4.21M5.19M5.22M6.25M7.21M7.41M7.30M10.06M7.75M6.65M7.23M10.07M6.76M6.87M4.98M7.93M4.44M4.32M
Operating Expenses (Quarter)
11.64M13.88M14.68M17.23M16.99M17.63M20.75M20.74M21.16M22.19M22.21M20.91M20.29M19.31M21.19M21.21M19.38M16.92M14.27M15.83M
Operating Income (Quarter)
-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M-11.23M-6.18M-10.23M
EBIT (Quarter)
-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M-11.23M-6.18M-10.23M
Non-operating items
Non Operating Interest Expenses (Quarter)
0.29M0.12M0.01M
Interest & Investment Income (Quarter)
0.05M0.08M0.09M0.48M1.39M1.95M2.30M2.56M2.70M2.82M2.75M2.59M2.50M2.30M2.03M1.87M1.73M1.63M1.44M1.36M
Other Non Operating Income (Quarter)
-0.24M0.08M0.09M0.48M1.28M1.94M2.30M2.56M2.70M2.82M2.75M2.59M2.50M-7.45M2.03M1.87M1.73M-4.39M1.44M1.36M
Net income details
EBT (Quarter)
-2.48M-4.87M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M-8.87M
Profit After Tax (Quarter)
-2.68M-4.87M-4.07M-8.26M-6.43M-4.81M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M-8.87M
Income from Continuing Operations (Quarter)
-2.48M-4.87M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M-8.87M
Consolidated Net Income (Quarter)
-2.48M-4.87M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M-8.87M
Income towards Parent Company (Quarter)
-2.48M-4.87M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M-8.87M
Net Income towards Common Stockholders (Quarter)
-2.48M-4.87M-29.52M-10.04M-30.81M-28.62M-10.88M-10.51M-11.25M-5.28M-9.53M-9.38M-11.56M-10.60M-10.26M-12.36M-12.42M-9.60M-4.75M-8.87M
Additional items
EPS (Basic) (Quarter)
-0.03-0.05-0.29-0.10-0.30-0.28-0.11-0.10-0.11-0.05-0.09-0.09-0.11-0.10-0.10-0.12-0.12-0.09-0.04-0.08
EPS (Diluted) (Quarter)
-0.03-0.05-0.29-0.10-0.30-0.28-0.11-0.10-0.11-0.05-0.09-0.09-0.11-0.10-0.10-0.12-0.12-0.09-0.04-0.08
Shares Outstanding (Quarter)
84.71M90.62M101.31M101.43M101.81M101.70M102.85M103.06M103.45M103.27M104.09M104.64M105.11M104.85M105.95M106.40M106.61M106.43M106.88M106.82M
Shares Outstanding (Diluted) (Quarter)
84.71M90.62M101.31M101.43M101.81M101.70M102.85M103.06M103.45M103.27M104.09M104.64M105.11M104.85M105.95M106.40M106.61M106.43M106.88M106.82M
EBITDA (Quarter)
-2.44M-4.96M-4.16M-8.74M-7.71M-6.75M-13.18M-13.07M-13.95M-8.10M-12.28M-11.97M-14.05M-12.90M-12.29M-14.23M-14.15M-11.23M-6.18M-10.23M
Interest Expenses (Quarter)
0.09M25.46M1.78M24.49M23.82M1.82M1.82M7.51M15.85M2.28M27.23M26.70M54.87M26.70M2.46M7.22M66.54M2.40M23.53M